EGFR and lung giant cell carcinoma: However, there is no confirmed evidence describing giant cell carcinoma of the lung in terms of its epidemiological features, including the EGFR mutation rate, or therapeutic efficiency to EGFR-TKIs of patients with sensitive EGFR mutations.